Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India flag India · Delayed Price · Currency is INR
212.50
+1.91 (0.91%)
Nov 12, 2026, 3:30 PM IST

NSE:SPARC Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
16,35815,532-3,425-3,872-2,226-2,034
Depreciation & Amortization
93.27101.67122.7123.26115.5799.47
Other Amortization
0.410.411.251.852.142.15
Loss (Gain) From Sale of Assets
2.022.42-0.33-0.61.13-48.93
Loss (Gain) From Sale of Investments
-18.4--10.55-31.81-32.65-4.64
Provision & Write-off of Bad Debts
---20.5--
Other Operating Activities
65.17621.57177.71-259.637.39164.11
Change in Accounts Receivable
-157.2282.58-4.28152.14-50.06-101.46
Change in Accounts Payable
83.22-182.18-292.88-58.9766.68-193.58
Change in Other Net Operating Assets
-805.38-18,546-171.46-366.58694.4734.51
Operating Cash Flow
15,621-2,388-3,603-4,292-691.18-2,082
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-28.71-238.31-103.4-265.08-153.87-326.78
Sale of Property, Plant & Equipment
8.192.995.954.854.6581.02
Investment in Securities
-12,701-1,5293,952-5,352-47.71
Other Investing Activities
38.750.35145.48223.7218.691.8
Investing Cash Flow
-12,682-234.961,5773,915-5,483-291.67

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-21,1585,802644.122,2451,070
Total Debt Issued
18,38721,1585,802644.122,2451,070
Long-Term Debt Repaid
--18,202-3,725-204.04-3,024-2,646
Lease Payments
-18.78-23.48-35.08-29.4-28.68-20.92
Net Debt Issued (Repaid)
-4,1242,9562,077440.09-778.17-1,576
Issuance of Common Stock
1,500---7,0284,093
Other Financing Activities
-297.91-342.21-84.22-16.04-82.07-223.01
Financing Cash Flow
-2,9212,6141,993424.056,1682,293

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.690.790.120.02--0.02
Net Cash Flow
17.51-8.09-33.6647.46-6.41-80.8

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
15,592-2,626-3,706-4,557-845.05-2,409
Free Cash Flow Growth
------
Free Cash Flow Margin
80.72%-13.98%-516.45%-603.21%-35.39%-175.53%
Free Cash Flow Per Share
47.99-8.09-11.42-14.04-2.97-9.15
Levered Free Cash Flow
9,363-8,868-1,263-2,930-611.54-1,833
Unlevered Free Cash Flow
9,526-8,671-1,210-2,923-563.82-1,750
Free Cash Flow After Leases
15,573-2,650-3,741-4,586-873.73-2,430

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
297.91342.2184.2216.0482.07142.18
Cash Income Tax Paid
--316.39-88.2741.11-53.65-45.44
Change in Working Capital
-879.38-18,646-468.62-273.341,411-260.53